Trial intelligence / Profile preview

Dexmedetomidine versus propofol sedation during transesophageal echocardiography in cardiac patients

IRCT2016112731131N1Phase 2Completed

Sponsor
Iran University of Medical Sciences
Start
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of dexmedetomidine and propofol in cardiac disease (2 arms), sponsored by Iran University of Medical Sciences. Started Mar 2017; status: completed.

02

Drugs

dexmedetomidinepropofol
03

Conditions

cardiac disease

Beyond the preview

Go deeper on IRCT2016112731131N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016112731131N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call